Leptospirosis is a globally distributed zoonosis that poses a major public health problem in rural and urban areas of tropical regions. This infection is attributed to direct or indirect human contact with the urine of wild, synanthropic, or domestic animals infected with *Leptospira* bacteria ([@B11], [@B13]. Outbreaks of the disease in developed countries are usually associated with occupational exposure, tourism, and water sports events ([@B7], [@B18], [@B2], [@B9], [@B28]. Developing countries bear the greatest burden of the disease due to the precarious living conditions of the populations exposed to the main risk factors ([@B3], [@B21]. While there are currently both serological and molecular classifications of *Leptospira*, there is no direct correlation between them. A given serogroup is often found in several *Leptospira* species ([@B8], [@B1], [@B26]. For instance, the 14 described serovars of the Bataviae serogroup are found in *L. interrogans* sensu stricto (five serovars), *Leptospira santarosai* (five serovars), *Leptospira kirschneri* (one serovar), *Leptospira noguchii* (two serovars) and *Leptospira borgpetersenii* (one serovar) ([@B8]. According to studies based on DNA/DNA hybridisation, the genus *Leptospira* consists of 21 genomic species ([@B26]. Serological studies describe over 260 pathogenic serovars, grouped into 24 serogroups, and 60 saprophytic serovars ([@B8]. Given the high serological and genetic diversity of *Leptospira*, it is important to identify the circulating species/serovars in order to enhance leptospirosis prevention and control strategies. For example, serodiagnostic tests could be improved by the incorporation of specific antigens for known native species. Likewise, vaccines could be developed specific to serovars circulating in different regions. The majority of Colombian studies have been limited to investigating leptospirosis outbreaks or studying seroprevalence in specific populations in certain regions of the country ([@B27], [@B10], [@B20], [@B19], [@B12], [@B23]. However a few studies in Colombia have incorporated molecular and serological identification of clinical isolates by serological typing, multilocus sequence typing (MLST) and pulsed-field electrophoresis ([@B34], [@B29], [@B24], [@B25]). Since there is little information available about the genetic diversity of species and serovars in Colombia, it is important to identify the causative agents of human leptospirosis and its distribution in animal hosts and environmental sources.

MATERIALS AND METHODS
=====================

*Source of isolates of Leptospira* - Twenty-five *Leptospira* isolates were collected during the study. Nine of these isolates were obtained from blood sampling of patients diagnosed with leptospirosis from the municipalities of Apartadó (eight) and Puente Iglesias (one). Four isolates were obtained from the kidneys and blood of capuchin monkeys (*Cebus capucinus)* that died as a result of jaundiced leptospirosis in the municipality of Barbosa. Three isolates were obtained from urine samples from dogs in the city of Medellin, which were sent to the laboratory for suspected leptospirosis, and five isolates were obtained from kidney samples from *Rattus norvegicus* captured in the city of Medellin and the municipality Turbo. Finally, four isolates were obtained from environmental water sources collected in the municipalities of Triganá and Necoclí; these water sources are used as for human consumption. All isolates were grown in liquid EMJH medium supplemented with 10% EMJH enrichment medium (Becton-Dickinson Biosciences) at a temperature of 26-30ºC. The cultures were examined by dark field microscopy weekly for three months to detect *Leptospira* growth*.*

*DNA extraction* - DNA was extracted from 1 mL of culture. The turbidity of the bacterial suspensions was adjusted to 0.5 McFarland standards. DNA extraction was performed using Wizard Kit (Promega®, USA), according to the manufacturer's instructions for gram-negative bacteria. All experiments were performed at a concentration of 20 ng/µL DNA for isolates. Concentration and purity were determined by Nanodrop, while integrity was assessed by 1% agarose gel electrophoresis.

*Amidohydrolase gene amplification* - A 914-base pair fragment from the Amidohydrolase gene was amplified by polymerase chain reaction (PCR) using the primers F16S (GCGGATATGCCGAACAACCCG) and R16S (TCAAACGGGCTCCAGCCGCT). The reagent concentrations used for PCR standardisation were as follows: primers (0.4 μM), dNTPs (0.2 mM), buffer (1×), MgCl2 (1.5 mM), Taq polymerase (1 unit/reaction) and DNA (200 ng/μL). The final volume for each reaction was 25 μL. PCR was performed in a Perkin Elmer 9700 thermocycler. The thermal cycling profile was: one initial denaturation cycle at 94ºC for 5 min, followed by 35 cycles at 94ºC for 45 s, 64ºC for 1 min, 72ºC for 2 min and a final cycle at the extension temperature of 72ºC for 5 min.

*Species identification by phylogenetic analysis* - The Amidohydrolase genes from 19 *Leptospira* species were used as reference sequences. These were: (WP_010573489.1, WP_020772111.1, WP_003005945.1, WP_004442891.1, WP_002745964.1, WP_004768995.1, WP_010577276.1, WP_046951104.1, WP_000591986.1, WP_039948702.1, WP_020987613.1, WP_002972272.1, WP_039935685.1, WP_002977290.1, WP_015682624.1, WP_015676897.1, WP_004786049.1, WP_016546771.1, and WP_012387340.1). These sequences and those obtained from the isolates by sequencing were aligned using the ClustalX program ([@B15]). Phylogenetic analysis was performed with using MEGA6 phylogenetic software ([@B30]), using the Neighbour-Joining method with 1000 bootstrap replicates. Evolutionary distances were computed using the parametric method Kimura-2.

*Serovar identification by MLST* - Molecular identification of the *Leptospira* isolates was performed using MLST, as described by ([@B4]). In brief, seven genes that are constitutively expressed in *Leptospira* (glmU, pntA, sucA, tpiA, pfkB, mreA, and CaiB) were amplified and sequenced. Subsequently, these sequences were queried against a database (http://leptospira.mlst.net/) to determine their allelic profile and phylogenetic relationship to the reference strains previously included in the database.

*Serovar identification by pulsed field gel electrophoresis* - Pulsed field gel electrophoresis (PFGE) was performed using the *NotI* restriction enzyme to generate fingerprint patterns, as previously described by ([@B17]). Pulse marker 0.5-1000 kb (SIGMA) was used as a size standard. Fingerprint patterns were analysed using GelCompar II (Gel electrophoresis software, Applied Maths). Dendrograms were created from UPGMA cluster analyses based on the Dice band-based coefficient. Band comparison settings of 1.5% optimisation and 1% position tolerance were used. Fingerprint patterns for the clinical isolates were queried against a library of 19 reference serovars based on mean similarity. Those with fingerprint patterns matching reference patterns in the library were identified to serovar level ([@B31]).

*Serovar identification by monoclonal antibodies* - Monoclonal antibodies (F70C14, F70C24 and F70C12) were used to differentiate the Icterohaemorrhagiae and Copenhageni serovars. The reference immune sera were provided by the Royal Tropical Institute (KIT) in the Netherlands. The reference strains *L. interrogans* (serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, RGA) and *L. interrogans* (serogroup Icterohaemorrhagiae, serovar Copenhageni, M20) were used as controls for the tests. Serial dilutions (1/20) were performed to determine antibody titres ([@B31]).

*Clinical, laboratory and epidemiological data* - Five patients enrolled in this study were subjected to physical examinations. Peripheral blood samples were collected in the hospitals where these patients were admitted, and sent to the Colombian Institute of Tropical Medicine for laboratory tests (Indirect Immuno-fluorescence test (IIFT), microscopic agglutination test (MAT) and blood culture. Finally, the patients' possible exposure to potential risk factors was evaluated with an epidemiological survey.

RESULTS
=======

*Species identification by phylogenetic analysis* - The species patterns were divided into three main branches according to their pathogenicity status (pathogenic, intermediate, and saprophytic). Branch support values ranged between 20-100%, permitting the identification of 19 *Leptospira* species. Isolates from humans, dogs, rodents, and capuchin monkeys (*C. capucinus*) clustered with the pathogenic species. Isolates from humans and canines were identified as *L. santarosai (*branch support values of 100%), while isolates from capuchin monkeys and rodents were identified as *L. interrogans (*branch support values of 99%). Finally, isolates from environmental water sources were grouped with saprophytic species. These were identified as *L. meyeri (*branch support values of 100%, [Fig. 1](#f01){ref-type="fig"}, [Table V](#t5){ref-type="table"}).

Fig. 1: species identification by phylogenetic analysis of the Amidohydrolase gene. A diamond and square represent isolates of *Leptospira* and the reference species genetically related to isolates, respectively.

TABLE VSpecies level identification of twenty-five *Leptospira* isolates by phylogenetic analysis and identification to the serovar level from twenty-one *Leptospira* isolates by pulsed field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and monoclonal antibodiesCodeIsolateSourceOriginPhylogeneticMLSTMonoclonal antibody1JEThumanApartadó*L. santarosai*Canalzonae 2AIMhumanPuente Iglesias*L. santarosai*Canalzonae 3JEChumanApartadó*L. santarosai*Canalzonae 4MCOhumanApartadó*L. santarosai*Alice 5OVhumanApartadó*L. santarosai*Alice 6OLPhumanApartadó*L. santarosai*Alice 7JCMhumanApartadó*L. santarosai*Canalzonae 8LGhumanApartadó*L. santarosai*Alice 9VRhumanApartadó*L. santarosai*Alice 10C35*C. capucinus*Barbosa*L. interrogans*unidentifiedCopenhageni11C45*C. capucinus*Barbosa*L. interrogans*unidentifiedCopenhageni12C8011*C. capucinus*Barbosa*L. interrogans*unidentifiedCopenhageni13C51849*C. capucinus*Barbosa*L. interrogans*unidentifiedCopenhageni14P828canisMedellín*L. santarosai*Beye 15P046canisMedellín*L. santarosai*Beye 16P153canisMedellín*L. santarosai*Babudieri 17RN040*R. norvergicus*Turbo*L. interrogans*unidentifiedCopenhageni18RN046*R. norvergicus*Turbo*L. interrogans*unidentifiedCopenhageni19RN111*R. norvergicus*Turbo*L. interrogans*unidentifiedCopenhageni20RN235*R. norvergicus*Turbo*L. interrogans*unidentifiedCopenhageni21MIN 187*R. norvergicus*Medellín*L. interrogans*unidentifiedCopenhageni22NECO 007waterNecoclí*L. meyeri*  23TRIGA 30waterTriganá*L. meyeri*  24TRIGA 32waterTriganá*L. meyeri*  25TRIGA 37waterTriganá*L. meyeri*  

*Serovar identification by MLST* - MLST methodology was used to verify correct species identification results from the phylogenetic analysis of the Amidohydrolase gene, and to identify twelve isolates to the serovar level. Five isolates obtained from humans were identified as the *L. santarosai* serovar Alice, and four human isolates were identified as the *L. santarosai* serovar Canalzonae. Two isolates from canines were identified as the *L. santarosai* serovar Beye, and one canine isolate was identified as the *L. santarosai* serovar Babudieri. The four isolates from capuchin monkeys and five isolates from rodents could not be identified to the serovar level. There was a 100% correlation between the results obtained by MLST and those obtained by the phylogenetic identification method ([Tables I](#t1){ref-type="table"}, [V](#t5){ref-type="table"}). The environmental isolates were not identified to the serovar level by MLST, due to the absence of allelic profiles in the MLST database.

TABLE IIdentification to serovar level of 12 *Leptospira* isolates by multilocus sequence typing (MLST) methodologyCodeSpeciesSerogroupSerovarSTAllelic profileCountrySourceCZ188*L. santarosai*GrippotyphosaCanalzonae17641, 53, 52, 49, 57, 43, 43Panamáspiny rat1*L. santarosai*GrippotyphosaCanalzonae17641, 53, 52, 49, 57, 43, 43Colombiahuman2*L. santarosai*GrippotyphosaCanalzonae17641, 53, 52, 49, 57, 43, 43Colombiahuman3*L. santarosai*GrippotyphosaCanalzonae17641, 53, 52, 49, 57, 43, 43Colombiahuman7*L. santarosai*GrippotyphosaCanalzonae17641, 53, 52, 49, 57, 43, 43Colombiahuman1537U*L. santarosai*ShermaniBabudieri17240, 48, 47, 47, 52, 42, 42Perúpig16*L. santarosai*ShermaniBabudieri17240, 48, 47, 47, 52, 42, 42ColombiacanineCI40*L. santarosai*AutumnalisAlice17340, 53, 51, 48, 56, 44, 43Sri Lankahuman4*L. santarosai*AutumnalisAlice17340, 53, 51, 48, 56, 44, 43Colombiahuman5*L. santarosai*AutumnalisAlice17340, 53, 51, 48, 56, 44, 43Colombiahuman6*L. santarosai*AutumnalisAlice17340, 53, 51, 48, 56, 44, 43Colombiahuman8*L. santarosai*AutumnalisAlice17340, 53, 51, 48, 56, 44, 43Colombiahuman9*L. santarosai*AutumnalisAlice17340, 53, 51, 48, 56, 44, 43ColombiahumanAliceL. santarosaiMiniBeye17843, 51, 47, 48, 55, 45, 43Panamáspiny rat14*L. santarosai*MiniBeye17843, 51, 47, 48, 55, 45, 43Colombiacanine15*L. santarosai*MiniBeye17843, 51, 47, 48, 55, 45, 43Colombiacanine

*Pulsed-field gel electrophoresis standardisation* - Five isolates from rodents were identified by PFGE, as *L. interrogans* serovar Icterohaemorrhagiae or Copenhageni ([Fig. 2](#f02){ref-type="fig"}, [Table V](#t5){ref-type="table"}). There was a 100% correlation between the results obtained by PFGE and those obtained by MLST. Environmental, human, and canine isolates were not identified to the serovar level by PFGE, due to the insufficient number of cleavage events by the *NotI* enzyme on the genomes of these species.

Fig. 2: identification of five isolates from rodents by pulsed field gel electrophoresis (PFGE). The genomic restriction profiles were consistent with the profiles corresponding to serovar Icterohaemorrhagiae or serovar Copenhageni.

*Serovar identification by monoclonal antibodies* - Isolates from dogs and rodents that could not be identified to the serovar level using MLST or PFGE were identified using monoclonal antibodies as belonging to the Copenhageni serovar. The nine isolates had positive agglutination reactions with the monoclonal antibodies F70C24 and F89C12, with titres between 1/640 and 1/5120. They had no agglutination reaction with the monoclonal antibody F70C14, which is specific to the serovar Icterohaemorrhagiae ([Tables II](#t2){ref-type="table"}, [V](#t5){ref-type="table"}).

TABLE IIIdentification of nine isolates from rodents and capuchin monkeys (*Cebus capucinus*) by monoclonal antibodies. The agglutination reactions identified nine isolates belonging to serovar CopenhageniMonoclonal antibodySerogroup-specificSerovar-specificF70C14IcterohaemorrhagiaeIcterohaemorrhagiaeF70C24IcterohaemorrhagiaeCopenhageniF89C12IcterohaemorrhagiaeNo IcterohaemorrhagiaeAntigensMonoclonal antibody F70C14 titleF70C24 titleF89C12 titleRGA (serovar Icterohaemorrhagiae)20,480negativenegativeM20 (serovar Copenhageni)negative10,4202,560(10) C35negative20,4802,560(11) C45negative20,480640(12) C8011negative20,4805,120(13) C51849negative20,480640(17) RN040negative20,4802,560(18) RN046negative20,4801,280(19) RN111negative20,480640(20) RN235negative20,4805,120(21) MIN187negative20,480640

*Clinical, laboratory and epidemiological patient data* - The clinical histories and laboratory test results of five patients are shown in ([Table III](#t3){ref-type="table"}), according to random patient numbering (P1-P5) and the respective infecting serovar. The epidemiological features related to the main risk factors and the infecting serovar are shown in ([Table IV](#t4){ref-type="table"}). The *L. santarosai* serovar Canalzonae was found to be the causative agent of leptospirosis in three patients. One patient showed clinical signs and symptoms characteristic of Weil's disease. The *L. santarosai* serovar Alice was found to be the causative agent of leptospirosis in two patients. The patients infected with serovar Canalzonae came from urban areas and the patients infected with the serovar Alice came from rural areas.

TABLE IIIEpidemiological data from five patients diagnosed with leptospirosisEpidemiological DataPatient 1 Serovar CanalzonaePatient 2 Serovar CanalzonaePatient 3 Serovar CanalzonaePatient 4 Serovar AlicePatient 5 Serovar AliceAge713263948SexMaleMaleMaleMaleFemaleOccupationStudentStudentEmployeeFarmerHousewifeOriginUrban areaUrban areaUrban areaRural areaRural areaAqueductYesYesNoNoNoSewerageYesYesNoNoNoDrinking waterYesYesNoNoNoArtesian wellNoNoYesNoNoContact with miceYesYesYesYesYesContact with dogsNoNoYesYesYesContact with other mammalsNoNoYesYesYesBathing in streamsNoYesNoNoNoNearby farms floodedYesNoYesYesYes

TABLE IVClinical and laboratory data from five patients diagnosed with leptospirosisPatient / Infecting SerovarClinical Presentation and OutcomesLaboratory TestsSerological TestsP1 / CanalzonaeBiphasic fever, chills, severe headache, frequent coughing, nausea, inappetence, generalized erythema, tachycardia (HR 120). Positive tourniquet test. The clinical course featured a mild anicteric form.No recordsIIFT positive. Seroconvert in two serum samples. Negative to 1:80 for IgM and IgG antibodies.P2 / CanalzonaeFever, headache, malaise, ocular itching, conjunctival, persistent cough. Proof of the tourniquet (+). The patient responded well to treatment with Doxycycline. The clinical course featured a mild anicteric form.leukocytosis PMN: 88.4%; CRP 48 mg / dLIIFT positive. Seroconvert in two serum samples. Negative to 1:80 for IgM and IgG antibodies.P3 / CanalzonaeFever, chills, jaundice, general malaise, headache, myalgia, arthralgia, nausea, vomiting, diarrhea, abdominal pain, cough, nasal congestion, red eyes, gingival bleeding, hepatomegaly. The patient responded well to supportive care and to treatment with Ceftriaxone. The clinical course featured the classical Weil's syndrome.Leukocytosis (16410); PMN: 83.4%; CRP: 203,55 mg / dL, BT: 4.71; Hematuria (200/AP); Proteinuria (100 /) Hypocalcemia (Potassium: 2.86 MEQ / L).IIFT positive. Seroconvert in two serum samples. Negative to 1:80 for IgM and IgG antibodies. MAT positive, titer of 1:400 with serovar HardjoP4 / AliceFever, chills, general malaise, nausea, headache, retro-orbital pain, myalgia, arthralgia, back pain, tachycardia (HR 105). The patient progressed satisfactorily without antibiotic treatment during the acute phase of the disease. The clinical course featured a mild anicteric form.CRP: 96IIFT positive. Seroconvert in two serum samples. Negative to 1:80 for IgM and IgG antibodies. MAT positive, titer of 1:200 with the serovar Hardjo.P5 / AliceFever, chills, malaise, headache, myalgia, arthralgia, back pain, retro-orbital pain, nausea, diarrhea. The patient progressed satisfactorily during their hospital management. No records of antibiotic treatment. The clinical course featured a mild anicteric form with hepatic changes.CRP: 229,5 GPT: 147,6IIFT positive with seroconvert titles from 0 (negative) to 1:160 for IgM antibodies and seroconvert from 1:20 to 1:160 for IgG antibodies.

DISCUSSION
==========

Characterisation of the genetic diversity of *Leptospira* species and serovars distributed in the environment, including in both reservoirs and accidental hosts, is highly advantageous for improvement of serological diagnosis, immunoprophylaxis, prevention, and control of the disease. The incorporation of native serovar antigens would increase the sensitivity of serological tests, and enable the development of more effective vaccines that target specific serovars circulating in given regions. In addition, the identification of disease reservoirs further aids in the development of prevention and control strategies, such as those aiming to minimise the dispersion of *Leptospira* bacteria in the environment and decreasing human contact with infected animals.

Human and canine isolates were identified as *L. santarosai*. This is the first report documenting the Canalzonae, Babudieri, Alice and Beye serovars as causes of human or animal leptospirosis in Antioquia, Colombia. However, this species is a known causative agent of human leptospirosis in Costa Rica and the French West Indies ([@B32], [@B5]). Previous studies in Peru also suggest the ubiquity of *L. santarosai* and the possibility of animal hosts. *L. santarosai* has been isolated from rats, marsupials, and humans and has also been found in samples taken from the surrounding environment ([@B22]). While Brazil and Mexico have not reported cases of human leptospirosis yet, this species has been found to infect buffalo and cattle in these countries ([@B33], [@B6]).

The sensitivity of the MAT may be improved by including local strains or serovars, mainly those belonging to the species *L. santarosai*. Likewise, more effective vaccines could be developed by considering these serovars in their antigenic composition. The isolates from capuchin monkeys and rodents were identified as *L. interrogans*; this species is the major causative agent of leptospirosis worldwide ([@B16]). In Colombia, *L. interrogans* has been found to infect capuchin monkeys, rodents and pigs ([@B29], [@B24], [@B25]).

Copenhageni and Icterohaemorrhagiae serovars are normally included in serological tests and vaccines. Since molecular identification by MLST and PFGE could not differentiate between Copenhageni and Icterohaemorrhagiae serovars, it was necessary to use monoclonal antibodies to differentiate between these serovars. The results indicate that rodent and capuchin monkey isolates belonged to the Copenhageni serovar ([Table II](#t2){ref-type="table"}).

The isolates from environmental water sources were identified as *L. meyeri* species, which is difficult to taxonomically classify due to it pathogenic serovars, such as Sophia, and saprophytic serovars, such as Semaranga. Other *L. meyeri* serovars, for example Perameles and Ranarum, can be found in both pathogenic and saprophytic subgroups ([@B14]). Therefore, it is important to control the presence of this species in environmental water sources, due to its potential pathogenicity. The identification of these species in environmental water samples is also indicative that certain pathogenic strains may be able to temporarily survive outside of their animal hosts. The saprophytic *L. meyeri* species has not been reported in Colombia.

For epidemiological purposes, it is important to note that the three isolates identified as serovar Canalzonae came from patients living in urban areas, while isolates of serovar Alice infected patients living in rural areas. The common epidemiological factor reported for all five patients was contact with rodents in their homes ([Table III](#t3){ref-type="table"}). In terms of clinical characteristics, two cases (P1 and P2) were paediatric patients (under 15 years) infected with the serovar Canalzonae. One presented a biphasic course and increased indicators of acute phase disease (leucocytosis and CRP). Both patients exhibited haemorrhagic manifestations, which were evaluated by the tourniquet test. They had mild forms of leptospirosis, which were treated with amoxicillin and doxycycline. Patient P3, also infected by the serovar Canalzonae, presented clinical signs and symptoms matching Weil's syndrome ([Table IV](#t4){ref-type="table"}). The patients infected with the Alice serovar (P4 and P5) also presented with acute febrile illness with systemic manifestations. One of them required hospital management for hepatitis, and had increased ALT (160.2 mg/dL), and increased total bilirubin (2.29 mg/dL) at the expense of direct bilirubin (1.8 mg/dL). Other laboratory examinations showed a tendency toward leucopoenia, with mild thrombocytopaenia and enhanced CRP (227.5 mg/dL) ([Table IV](#t4){ref-type="table"}). The symptomatology of patients infected with the Canalzonae and Alice serovars reflects the ability of *L. santarosai* to produce clinical symptoms ranging from mild to severe, including Weil's syndrome and liver failure. Although other bacterial diseases can also cause increased acute phase proteins, this particular symptom may help in clinical management of the disease, mainly by aiding in the differentiation of leptospirosis from malaria, dengue, or other viral infections in patients with acute febrile disease. The interaction between animals and human and its effect on public health is an open field for research. It is important to establish the main reservoirs of the disease in order to evaluate the magnitude of leptospirosis in Colombia.
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